TYPE 2 DIABETES MELLITUS, RECURRENT DEPRESSIVE DISORDER AND ANXIETY DISORDERS
DOI:
https://doi.org/10.15547/tjs.2024.04.009Keywords:
Diabetes, mellitus, depression, anxietyAbstract
There are gender differences in the comorbidity of major depressive disorder, anxiety disorders, and type 2 diabetes, according to several studies. New research reveals that insulin and insulin signalling are connected to neurotransmission of several significant neurotransmitters, as well as neuro-modulation and neuroprotection, refuting the notion that the brain is insulin insensitive. Brain insulin resistance, which may result from peripheral insulin resistance, has been linked to depressive symptoms through changes in neuronal functions. Antidepressant effects may be enhanced by IGF-I's direct stimulation of neurogenesis. Other widely accepted pathophysiological mechanisms that have been proposed by several authors include GR, MR, HPA, adipokine hormones such as ghrelin and the orexigenic hormone, as well as pro-inflammatory factors and adiponectin, leptin, and resistin.
References
Vos T, Alemu Abajobir A, Hassen Abate K, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990^aV‘‘2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet;390:1211e1259. 2017
Vancampfort D, Mitchell AJ, De Hert M, Sienaert P, Probst M, Buys R, Stubbs B. TYPE 2 DIABETES IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A META-ANALYSIS OF PREVALENCE ESTIMATES AND PREDICTORS. Depress Anxiety.;32(10):763-73. Oct 2015
Mendenhall E, Norris SA, Shidhaye R, Prabhakaran D. Depression and type 2 diabetes in low- and middle-income countries: a systematic review. Diabetes Res Clin Pract.;103(2):276-85. Feb 2014
Semenkovich K, Brown ME, Svrakic DM, Lustman PJ. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs.;75(6):577-87. Apr 2015
Rotella F, Mannucci E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry.;74(1):31-7. Jan 2013
Siddiqui, S.. Depression in type 2 diabetes mellitus—A brief review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 8(1), 62–65. 2014
Perrin NE, Davies MJ, Robertson N, Snoek FJ, Khunti K. The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med.;34(11):1508-1520. Nov 2017
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care.;24(6):1069-78. Jun 2001
Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord.;142 Suppl:S8-21. Oct 2012
Wang Y, Lopez JM, Bolge SC, Zhu VJ, Stang PE. Depression among people with type 2 diabetes mellitus, US National Health and Nutrition Examination Survey (NHANES), 2005-2012. BMC Psychiatry. 5;16:88. Apr 2016
Yang, Q.-Q., Sun, J.-W., Shao, D., Zhang, H.-H., Bai, C.-F., & Cao, F.-L. The Association between Diabetes Complications, Diabetes Distress, and Depressive Symptoms in Patients with Type 2 Diabetes Mellitus. Clinical Nursing Research, 105477382095193. 2020
Hessler, D., Fisher, L., Strycker, L. A., Arean, P. A., & Bowyer, V.. Causal and bidirectional linkages over time between depression and diabetes regimen distress in adults with type 2 diabetes. Diabetes Research and Clinical Practice, 108(2), 360–366. 2015
Swardfager W, MacIntosh BJ. Depression, Type 2 Diabetes, and Poststroke Cognitive Impairment. Neurorehabil Neural Repair. 31(1):48-55. Jan 2017
Gulley LD, Shomaker LB. Depression in Youth-Onset Type 2 Diabetes. Curr Diab Rep. 28;20(10):51. Aug 2020
Dibato J, Montvida O, Ling J, Koye D, Polonsky WH, Paul SK. Temporal trends in the prevalence and incidence of depression and the interplay of comorbidities in patients with young- and usual-onset type 2 diabetes from the USA and the UK. Diabetologia.;65(12):2066-2077. Dec 2022
Shirali A, M Y, Shirali PA, Sarah. Depression in Diabetes-The Hidden Bane. Ann Neurosci.;30(3):163-168. Jul 2023
Mikaliūkštienė A, Žagminas K, Juozulynas A, Narkauskaitė L, Sąlyga J, Jankauskienė K, Stukas R, Šurkienė G. Prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes in Lithuania. Med Sci Monit. 4;20:182-90. Feb 2014
Lipscombe C, Smith KJ, Gariépy G, Schmitz N. Gender differences in the relationship between anxiety symptoms and physical inactivity in a community-based sample of adults with type 2 diabetes. Can J Diabetes. ;38(6):444-50. Dec 2014
Moran, Chelsea MA; Flynn, Michelle MSc; Campbell, Tavis PhD, RPsych; Rouleau, Codie PhD, RPsych; Arena, Ross PhD, PT; Chirico, Daniele PhD; Aggarwal, Sandeep MD; Laddu, Deepika PhD Author Information Journal of Cardiopulmonary Rehabilitation and Prevention 41(5):p 328-335, September 2021.
Weaver LJ, Madhu SV. Type 2 Diabetes and Anxiety Symptoms Among Women in New Delhi, India. Am J Public Health. ;105(11):2335-40. Nov 2015
Park M, Reynolds CF 3rd. Depression among older adults with diabetes mellitus. Clin Geriatr Med.;31(1):117-37, ix. Feb 2015
Iversen MM, Nefs G, Tell GS, Espehaug B, Midthjell K, Graue M, Pouwer F. Anxiety and Depressive Symptoms as Predictors of All-Cause Mortality among People with Insulin-Naïve Type 2 Diabetes: 17-Year Follow-Up of the Second Nord-Trøndelag Health Survey (HUNT2), Norway. PLoS One. 18;11(8):e0160861. Aug 2016
Naicker K, Øverland S, Johnson JA, Manuel D, Skogen JC, Sivertsen B, Colman I. Symptoms of anxiety and depression in type 2 diabetes: Associations with clinical diabetes measures and self-management outcomes in the Norwegian HUNT study. Psychoneuroendocrinology.;84:116-123. Oct 2017
Iversen MM, Nefs G, Tell GS, Espehaug B, Midthjell K, Graue M, Pouwer F. Anxiety, depression and timing of insulin treatment among people with type 2 diabetes: Nine-year follow-up of the Nord-Trøndelag Health Study, Norway. J Psychosom Res.;79(4):309-15. Oct 2015
Coley R, Alnababtah K. Are adults diagnosed with type 2 diabetes at a greater risk of developing depression? Integrative literature review. Br J Nurs. 10;31(5):266-273. Mar 2022
Athar M, Garg A, Khan MA, Parveen R, Kohli S, Vohora D, Nidhi. Metformin alone and in combination with sitagliptin induces depression and impairs quality of life in type 2 diabetes mellitus patients: An observational study. Int J Clin Pharmacol Ther.;61(3):102-110. Mar 2023
Tao H, Fan S, Zhu T, You L, Zheng D, Yan L, Ren M. Psychiatric disorders and Type 2 diabetes mellitus: A bidirectional Mendelian randomization. Eur J Clin Invest.;53(3):e13893. Mar 2023
Yu M, Zhang X, Lu F, Fang L. Depression and Risk for Diabetes: A Meta-Analysis. Can J Diabetes.;39(4):266-72. Aug 2015
Ong SL, Abbasi F, Watson K, Robakis T, Myoraku A, Rasgon N. Family history of diabetes moderates metabolic depression endophenotypes in overweight/obese adults. J Psychiatr Res.;151:583-589. Jul 2022
Joseph JJ, Golden SH. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci.;1391(1):20-34. Mar 2017
Graham, E. A., Deschênes, S. S., Khalil, M. N., Danna, S., Filion, K. B., & Schmitz, N. . Measures of Depression and Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis. Journal of Affective Disorders. 2020
Xuan L, Zhao Z, Jia X, Hou Y, Wang T, Li M, Lu J, Xu Y, Chen Y, Qi L, Wang W, Bi Y, Xu M. Type 2 diabetes is causally associated with depression: a Mendelian randomization analysis. Front Med.;12(6):678-687. Dec 2018
Geschwind DH, Flint J. Genetics and genomics of psychiatric disease. Science. 25;349(6255):1489-94. Sep 2015
Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., Murphy, G. M., & Schatzberg, A. F. (2016). HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Molecular Psychiatry, 22(4), 527–536. doi:10.1038/mp.2016.120
Tudpor K, Saisawai C, Kaewpho S, Jitseeda A. Psychological Stress Is a Risk Factor for Type 2 Diabetes Mellitus in College Students. Stud Health Technol Inform. 27;285:296-299. Oct 2021
Hamer JA, Testani D, Mansur RB, et al. Brain insulin resistance: a treatment target for cognitive impairment and anhedonia in depression. Exp Neurol; 315:1–8. 2019
An JH, Han KD, Jeon HJ. Higher metabolic variability increases the risk of depressive disorder in type 2 diabetes mellitus: a longitudinal nationwide cohort study. Front Psychiatry. 24;14:1217104. Jul 2023
Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry.;18(9):963-74. Sep 2013
Van Agtmaal, M. J. M., Houben, A. J. H. M., Pouwer, F., Stehouwer, C. D. A., & Schram, M. T. . Association of Microvascular Dysfunction With Late-Life Depression. JAMA Psychiatry, 74(7), 729. 2017
Sevilla-González, M. del R., Quintana-Mendoza, B. M., & Aguilar-Salinas, C. A. Interaction Between Depression, Obesity, and Type 2 Diabetes: A Complex Picture. Archives of Medical Research, 48(7), 582–591. 2017
Kurhe Y, Mahesh R. Mechanisms linking depression co-morbid with obesity: An approach for serotonergic type 3 receptor antagonist as novel therapeutic intervention. Asian J Psychiatr.;17:3-9. Oct 2015
Sudar-Milovanovic E, Gluvic Z, Obradovic M, Zaric B, Isenovic ER. Tryptophan Metabolism in Atherosclerosis and Diabetes. Curr Med Chem.;29(1):99-113. 2022
Papachristou S, Papanas N. Reduction of Depression in Diabetes: A New Pleiotropic Action of Metformin? Diabetes Ther.;12(4):965-968. Apr 2021
Subba R, Sandhir R, Singh SP, Mallick BN, Mondal AC. Pathophysiology linking depression and type 2 diabetes: Psychotherapy, physical exercise, and fecal microbiome transplantation as damage control. Eur J Neurosci.;53(8):2870-2900. Apr 2021
de Almeida Faria ACR, Dall'Agnol JF, Gouveia AM, De Paiva CI, Segalla VC, Ogata FE, Baena CP. Cognitive Performance and Diabetic Retinopathy: What Your Eyes Can Reveal About Your Brain. Curr Diabetes Rev. ;19(9):e050822207323. 2023
Wang J, Zhou D, Dai Z, Li X. Association Between Systemic Immune-Inflammation Index and Diabetic Depression. Clin Interv Aging. 11;16:97-105. Jan 2021
Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol.;3(6):461-471. Jun 2015
De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M. Brain corticosteroid receptor balance in health and disease. Endocr Rev.;19(3):269-301. Jun 1998
Sayadi AR, Seyed Bagheri SH, Khodadadi A, Jafari Torababadi R. The effect of mindfulness-based stress reduction (MBSR) training on serum cortisol levels, depression, stress, and anxiety in type 2 diabetic older adults during the COVID-19 outbreak. J Med Life.;15(12):1493-1501. Dec 2022
Sang YM, Wang LJ, Mao HX, Lou XY, Zhu YJ, Zhu YH. Correlation of lower 2 h C-peptide and elevated evening cortisol with high levels of depression in type 2 diabetes mellitus. BMC Psychiatry. 6;20(1):490. Oct 2020
Prabu P, Poongothai S, Shanthirani CS, Anjana RM, Mohan V, Balasubramanyam M. Altered circulatory levels of miR-128, BDNF, cortisol and shortened telomeres in patients with type 2 diabetes and depression. Acta Diabetol.;57(7):799-807. Jul 2020
Tyagi K, Agarwal NB, Kapur P, Kohli S, Jalali RK. Evaluation of Stress and Associated Biochemical Changes in Patients with Type 2 Diabetes Mellitus and Obesity. Diabetes Metab Syndr Obes. 16;14:705-717. Feb 2021
Haroon, E., Miller, A. H., & Sanacora, G. Inflammation, Glutamate and Glia: A Trio of Trouble in Mood Disorders. Neuropsychopharmacology, 42(1), 193–215. 2016
Raison, C. L., & Miller, A. H. Pathogen–Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance. Neuropsychopharmacology, 42(1), 5–27. 2016
Hoshikawa T, Okamoto N, Natsuyama T, Fujii R, Ikenouchi A, Honma Y, Harada M, Yoshimura R. Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation. Neuropsychiatr Dis Treat. 3;18:173-186. Feb 2022
Ajilore O, Narr K, Rosenthal J, Pham D, Hamilton L, Watari K, Elderkin-Thompson V, Darwin C, Toga A, Kumar A. Regional cortical gray matter thickness differences associated with type 2 diabetes and major depression. Psychiatry Res. 30;184(2):63-70. Nov 2010
Tian J, Liu RF, Li ZL, Tan J, Lu YS, Zhang WW, Liu JX, Gong R, Cao JC, Yang C, Huang G, Wang Y, Zhao LP. Alterations of Spontaneous Cortical and Subcortical Activity in Type 2 Diabetes Mellitus with and without Depression. Neuroendocrinology.;113(7):736-755. 2023
Thummasorn S, Apichai S, Chupradit S, Sirisattayawong P, Chaiwong P, Sriwichaiin S, Pratchayasakul W, Chattipakorn N, Chattipakorn SC. T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients. PLoS One. 19;17(8):e0273327. Aug 2022
Damanik J, Yunir E. Type 2 Diabetes Mellitus and Cognitive Impairment. Acta Med Indones.;53(2):213-220. Apr 2021
Harding KA, Pushpanathan ME, Whitworth SR, Nanthakumar S, Bucks RS, Skinner TC. Depression prevalence in Type 2 diabetes is not related to diabetes-depression symptom overlap but is related to symptom dimensions within patient self-report measures: a meta-analysis. Diabet Med.;36(12):1600-1611. Dec 2019
Zhang DA, Lam V, Chu V, Li M. Type 2 Diabetes with Comorbid Depression in Relation to Cognitive Impairment: an Opportunity for Prevention? Mol Neurobiol.;55(1):85-89. Jan 2018
Willame H, Wacquier B, Point C, Dosogne M, Al Faker M, Loas G, Hein M. The association between type 2 diabetes and anhedonic subtype of major depression in hypertensive individuals. J Clin Hypertens (Greenwich).;24(2):156-166 Feb 2022
Silva N, Atlantis E, Ismail K. A review of the association between depression and insulin resistance: pitfalls of secondary analyses or a promising new approach to prevention of type 2 diabetes? Curr Psychiatry Rep.;14(1):8-14. Feb 2012
Yang W, Liu M, Tian Y, Zhang Q, Zhang J, Chen Q, Suo L, Chen Y. The increased prevalence of depression and anxiety in T2DM patients associated with blood glucose fluctuation and sleep quality. BMC Endocr Disord. 17;22(1):232. Sep 2022
Kec D, Rajdova A, Raputova J, Adamova B, Srotova I, Nekvapilova EK, Michalcakova RN, Horakova M, Belobradkova J, Olsovsky J, Weber P, Hajas G, Kaiserova M, Mazanec R, Potockova V, Ehler E, Forgac M, Birklein F, Üçeyler N, Sommer C, Bednarik J, Vlckova E. Risk factors for depression and anxiety in painful and painless diabetic polyneuropathy: A multicentre observational cross-sectional study. Eur J Pain.;26(2):370-389. Feb 2022
Inoue K, Beekley J, Goto A, Jeon CY, Ritz BR. Depression and cardiovascular disease events among patients with type 2 diabetes: A systematic review and meta-analysis with bias analysis. J Diabetes Complications.;34(12):107710. Dec 2020
Qiu, C., Sigurdsson, S., Zhang, Q., Jonsdottir, M. K., Kjartansson, O., Eiriksdottir, G., … Launer, L. J. Diabetes, markers of brain pathology and cognitive function. Annals of Neurology, 75(1), 138–146. 2014
Alghafri RM, Gatt A, Formosa C. Depression Symptoms in Patients with Diabetic Peripheral Neuropathy. Rev Diabet Stud.;16(1):35-40. 2020
Al-Yousif N, Rawal S, Jurczak M, Mahmud H, Shah FA. Endogenous Glucose Production in Critical Illness. Nutr Clin Pract.;36(2):344-359. Apr 2021
Nyenwe EA, Kitabchi AE. The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management. Metabolism J.metabol;65:507-21. 2016
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Trakia University
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
